Precision mental health - Pioneering personalised blood based biomarkers for predicting mental illness and treatment response.
Mental Health For You
Mission
At Ketim Therapeutics, our mission is to revolutionise mental health care by pioneering the discovery and application of blood based biomarkers for the early detection, prediction, and treatment of mental health conditions, with a particular focus on perinatal and postnatal depression.
1 in 5 mothers and 1 in 10 fathers experience anxiety and/or depression during the perinatal and postnatal periods. There is an urgent unmet need to identify those at risk early, and provide earlier intervention, as well as monitor the treatment response using objective biomarkers.
Perinatal Depression affects Families
Vision
Our vision is to lead the future of mental health care by integrating cutting-edge biomarker technologies into clinical practice and identifying novel therapeutics for mental illness.
We envision a world where mental health conditions are identified and treated with the same precision as physical illnesses, ensuring that every individual receives personalised, effective care.
“Having suffered from postnatal depression myself, my lived experience have driven my passion to help other Mums at a time when it seems no one is. My own suffering need not be in vain.”
- Dr Clarissa Yates, CEO
The Problem: Currently, there are no objective clinically relevant biomarkers to inform clinical care and identify those at risk of developing postpartum depression.
Our Solution: Using an identified biomarker signature profile, we aim to develop predictive biomarker screening panels combined with our proprietary analytics to predict postpartum depression before onset, helping the lives of millions worldwide.
